October 26th, 2023

Life Sciences BC seeks to raise the profile of our members and supporters, highlight their achievements, and promote BC's dynamic life sciences ecosystem. If you have news or a story to share, let us know. You can find previous editions of BioLinks newsletters and other resources on our website at News/Publications.

When considering the sector's future, Dr. Burt emphasized the importance of fostering a culture of diversity, equity and inclusion, maintaining strong support for quality research – the foundation of our sector; and supporting the ecosystem of provincial and federal organizations that aim to catalyze growth.

Thank you to Dr. Burt for your outstanding contributions that will continue to bear fruit in the years to come, and to event participants Gordon McCauley of adMare, Dr. Pieter Cullis of The University of British Columbia, and the panel led by Kirk LaPointe featuring Dr. Clement Mugabe of Evonik, Dr. Edie Dullaghan, Kelly Lendsay of Indigenous Works, and our Board Chair Ali Ardakani of Novateur Ventures. 

We also hosted a lunch this week to say goodbye to our departing board members. Thanks to Dr. Pieter Cullis, Dr. James Taylor, Ian Heine, CA, Pascal Spothelfer, and Dr. Gavin Stuart for their invaluable time, knowledge, and guidance. You have all helped shape our organization's success. See our related press release here.

Member Highlights 

STEMCELL Technologies has announced its new Canadian sales office located at downtown Toronto’s MaRS Centre, North America's largest urban innovation hub. This strategic move expands STEMCELL's presence in North America. Learn more.

Digital Supercluster has announced its re-investment in the Canadian Tech Talent Accelerator (CTTA) project led by NPower Canada in collaboration with CIBC, Microsoft and the Government of Canada. This initiative aims to empower thousands of job seekers across Canada to pursue tech industry careers, including cybersecurity, data analytics and visualization, IT service management, and artificial intelligence. Learn more. 

Managing Partner of Pender Ventures, Maria Pacella, was recently featured on the CIBC Innovation podcast, providing her insights into the world of venture capital and why it’s the people that matter. Listen here.

Jim Kean of Molecular You was recently featured in a TechStrong.ai article on how the company is leveraging innovative AI technology for early detection of vision loss. Read it here.

Vancouver Coastal Health Research Institute researcher Dr. Eduardo Navajas is leading a groundbreaking clinical trial on the first-ever exploration of gene therapy for patients with wet age-related macular degeneration. Learn more here.

Tamer Mohamed of Aspect Biosystems was recently featured on BNN Bloomberg to discuss the company's development of bioprinted tissues to treat incurable diseases, and its partnership with Novo Nordisk. Watch it here.

Innovative Medicines Canada has released its 2023 Cost Drivers Report, which provides an analysis of Canadian private drug plans. Read it here.

Researchers from the UBC Faculty of Medicine and the BC Children's Research Institute have launched a new online tool to help caregivers and educators support outdoor play and learning for children, including how to transition to teaching outdoors, bridge risky play and learning, supervise risky play, and make learning visible. Learn more.

New Members

Cozen O’Connor is a full-service firm with award-winning practices in litigation, business law, and government relations, and their attorneys have experience operating in all sectors of the economy. 

Ascinta Technologies Inc. provides a web-based platform and application ecosystem for simplifying medical image analysis in clinical trials. 

Canadian Nano Pharmaceutical Technology Inc. (CNANO) is a pioneering pharmaceutical company focused on advanced drug delivery. 

D2type Health is innovating in the realm of digital health and providing a transformative Diabetes health platform. 

EyeCareX Technologies' goal is to digitize elements of the eye exam and eye exam process, allowing for an entirely new eye health patient journey. 

Welcome all to the LSBC community!

Industry Highlights

The Consulate General of Canada in Dubai invites Canadian life sciences companies to participate in Trade Commissioner Service (TCS) programming at Arab Health on January 29 – February 1, 2024 in Dubai. With 130,000+ visitors and 3,300+ exhibitors from 76 countries, Arab Health is a key event for the healthcare industry in the Middle East and North Africa (MENA). The TCS will organize activities for attending Canadian companies, allowing SMEs to connect with various business contacts, including local distributors/re-sellers, buyers, government agencies and accelerators/incubators. The TCS is also collecting expressions of interest for an Arab Health add-on trade mission to Jordan, Saudi Arabia and Kuwait. To learn more, contact Jenny Karnjanavijaya.

To advance research infrastructure and bolster BC’s global competitiveness, the province has announced $2.5M in funding for 16 innovative research projects at five BC universities via its B.C. Knowledge Development Fund (BCKDF). Learn more about the exciting research projects supported by these funds here.

Canada has announced $9.9M in funding to Innovate BC to help BC tech companies scale by connecting them with large-scale B.C. organizations looking for sustainable solutions. Provided via PacifiCan’s Regional Innovation Ecosystems program, this funding is in addition to $11.5 million provided by the Government of B.C. Learn more.

Canada has announced an investment of $26.6 million, made possible through the Canadian Institutes of Health Research (CIHR) and its partners. This funding will support collaborative efforts between researchers, policymakers, healthcare providers, and individuals with lived or living experiences to improve the health of people in Canada through integrated care policies and practices. Learn more.

Canada has announced $500K for the Canadian Council for Aboriginal Business (CCAB) to help increase and improve the tools and resources Indigenous small business owners and entrepreneurs need to play a more significant part in Canada’s economy. Learn more.

The Public Health Agency of Canada has updated its Health of People in Canada Dashboard, an interactive tool providing accessible and understandable data on the health of Canadians. This data empowers decision-makers to enhance public health. See it here. 

Kudos

Congratulations to Drs. Babak Shadgan and Brian Kwon of UBC’s Faculty of Medicine, recipients of a prestigious $2.3 million research grant from the US Congressionally Directed Medical Research Programs (CDMRP) for their work on spinal cord tissue oxygenation in acute spinal cord injuries. Learn more.

Kudos to Dr. Pamely Hoodless of UBC’s School of Biomedical Engineering for receiving the Canada Research Society & Canadian Liver Foundation grant for the work “Exploring epigenetic alteration in liver cancer at single cell resolution.” Learn more.

Congratulations to the winners of this year’s CAN Health Network Awards, which recognizes individuals and organizations transforming health care in Canada and leading the new healthcare economy. See them here.

People on the Move

Dr. Benoit-Antoine Bacon, award-winning teacher and active researcher working on the neurophysiological and cognitive bases of visual and multisensory perception, joins UBC as its new President and Vice-Chancellor, effective Nov. 1. Learn more.

Canada has appointed intensive care physician and Adjunct Assistant Professor at Queen's University, Dr. Emily A. Reynen, to its Patented Medicine Prices Review Board (PMPRB) for a five-year term. Learn more.

Berkley Canada welcomes Catherine Felepchuk as its new Vice President of Distribution, Communication, & Product.

The Canadian Institutes of Health Research welcomes Dr. Katherine Frohlich as the new Scientific Director of CIHR's Institute of Population and Public Health. Learn more about her vision for the organization here.

Applications Open

Applications are now open for Michael Smith Health Research BC's Scholar and Health Professional-Investigator (HP-I) awards, which provide a maximum of $90,000 in funding per year for up to five years to support BC's health researchers in advancing science and improving the health of British Columbians. An information session will be held on Nov 1. The letter of intent deadline is Nov 21. The full application deadline is Jan 29, 2024. Learn more.

The Society for Canadian Women in Science and Technology has called for volunteers for its SCWIST STEM Explore Workshops in the lower mainland to inspire the next generation of STEM enthusiasts! Learn more and apply here.

Eureka has launched a Globalstars call for proposals for joint R&D projects in the high-tech and sustainability sectors with at least one eligible Taiwanese partner. This call for proposals is open to organizations who wish to form project consortia to perform collaborative projects focused on developing innovative products, processes, or technology-based services. The Canadian registration deadline is Feb 19, 2024. Learn more.

The European-Canadian Centre for Innovation and Research (ECCIR) invites Canadian companies looking for international collaborators to participate in the free "Open Innovation Challenge 2024" at the Mobile World Congress in Barcelona in February 2024. Applications are due Nov 15. Learn more.

We invite you to explore our expanded list of current life sciences application opportunities by clicking following link: Applications Open.

#ICYMI

The 8th annual Invest in BC presented by Lumira Ventures, on Nov. 2 serves as a premier gathering for healthcare innovators in British Columbia, connecting them with global investors for pitches and presentations.

Our Showcase Series: Kelowna returns to the Okanangan on Nov. 8! This highly anticipated annual event shines a spotlight on the region's growing life sciences sector.

The Last Word

For those who like to get an early start on your personal and corporate holiday gift shopping, check out the Greater Vancouver Board of Trade’s Trade Accelerator Program (TAP) Alumni Holiday Shopping Guide and support local businesses!

Until next week,

Wendy and the LSBC team

LifeLabs and BCIT Collaborate to Launch Innovative Global Chapter on Blood Tests in Open Education Pathology Textbook

LifeLabs and the British Columbia Institute of Technology are excited to announce their collaboration on the latest chapter of a groundbreaking Open Education Pathology Textbook, a collaboration between BCIT and UBC. This new chapter, centred around blood and blood tests, offers an engaging and informative resource that transcends borders, benefiting healthcare professionals, students, and curious minds across the globe... READ MORE

Scholar and Health Professional-Investigator Programs: 2024 Competitions Now Open

Michael Smith Health Research BC’s Scholar and Health Professional-Investigator (HP-I) awards provide funding to support BC’s health researchers in advancing science and improving the health of British Columbians. Applications are now open for our 2024 competitions. Through supporting outstanding health researchers, we help enable discovery-based research and the translation of that research to new treatments, cures, practices, and solutions that improve the health of British Columbians... READ MORE

STEMCELL Technologies Expands into Toronto’s MaRS Centre, Grows North American Presence

Located in the city’s Discovery District, the MaRS Centre is North America’s largest urban innovation hub. Consisting of over 1.5 million square feet, it hosts a curated roster of more than 120 tenants, including globally recognized research labs, tech corporates, capital providers, and many of Canada’s most promising health and life sciences startups... READ MORE

WELL Health’s Cycura Announces Two Tuck-In Acquisitions to Enhance Patient Data Protection and Appoints New Management

WELL’s Cybersecurity Business Unit, Cycura, has acquired Seekintoo, a provider of Cybersecurity Operations Center services, ensuring enterprise clients receive 24/7 vigilant threat protection through managed detection. Cycura has also acquired Proack, a premier provider of offensive security assessments, including high quality penetration testing, red teaming, social engineering, and infrastructure testing... READ MORE

Breathing New Life Into Patient Care: Innovative Partnership Aims to Transform Interstitial Lung Disease Support

In a unique partnership, Boehringer Ingelheim (Canada) Ltd., St. Joseph’s Healthcare Hamilton, and McMaster University have come together to transform the way patients are supported at the onset of a diagnosis related to interstitial lung disease (ILD). This collaboration marks a significant leap forward in patient-centric care, driven by empathy and understanding. The outcome—the creation of the myILD Kit... READ MORE

Cytiva and RoosterBio Collaborate to Address Exosome Manufacturing Challenges

Biotechnology leaders Cytiva and RoosterBio, Inc., are teaming up to develop a purification process to manufacture exosomes in mass quantities. This collaboration brings together the strengths of both companies to solve one of the biggest challenges currently limiting the use of exosomes as therapeutics and as delivery vehicles for gene therapies and other biologics... READ MORE

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) is Available for the First-Line Treatment of Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC)

Merck (NYSE: MRK) and Eisai announced that KEYTRUDA®, an anti-PD-1 therapy, in combination with LENVIMA®, the multiple receptor tyrosine kinase inhibitor discovered by Eisai, is reimbursed under the Alberta, British Columbia, Nova Scotia, Ontario, Quebec, and Saskatchewan drug plans with respective clinical criteria and conditions for adult patients with advanced (not amenable to curative surgery or radiation) or metastatic renal cell carcinoma (RCC), with no prior systemic therapy for metastatic RCC... READ MORE

Mintz’s Nationally-Recognized Life Sciences Practice Continues to Strengthen

Y. Jenny Chen, PhD has joined Mintz as a Member in the firm’s highly-regarded Intellectual Property (IP) practice, adding further expertise and depth to the firm’s life sciences offering. “Jenny is a highly regarded life sciences patent attorney and IP strategist. She has depth of experience in the areas of antibodies, cell therapies, and gene editing that will enhance our capabilities servicing clients in the life sciences sector,” said Managing Member, Bob Bodian... READ MORE

BIOMEDevice Silicon Valley 2023: StarFish Medical Exhibits

StarFish Medical, one of North America’s largest medical device design companies, will exhibit in booth 722 at BIOMEDevice Silicon Valley 2023, November 15-16, 2023 at the Convention Center in Santa Clara, CA. If you’re a medical device company interested in designing and developing a novel medical device, or you’re looking to transfer your device from the lab to manufacturing so you can scale to the point of exit or higher volume, our team would be pleased to speak with you... READ MORE

NPower Canada’s Workforce Development Program Receives $2M Investment From Digital, Microsoft, and the Cibc Foundation to Empower 6,000 Job-Seekers

NPower Canada has announced the continued co-investment of DIGITAL, working together with Microsoft and the CIBC Foundation, of $2 million to scale the Canadian Tech Talent Accelerator (CTTA). This initiative is designed to launch more than 6,000 job-seekers across Canada into meaningful careers in tech... READ MORE

InMed Pharmaceuticals Inc.’s INM-901 Demonstrates Unique Pharmacological Effects in Alzheimer’s Disease in Preclinical Proof-of-Concept Studies

InMed Pharmaceuticals Inc. announced it has selected a lead Alzheimer’s disease drug candidate, named INM-901, following positive results from several proof-of-concept studies in a validated Alzheimer’s disease treatment model. InMed will be advancing INM-901, a cannabinoid analog, in its pharmaceutical drug development program... READ MORE

InMed Pharmaceuticals Announces $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market under Nasdaq Rules

InMed Pharmaceuticals Inc. announced that it has entered into definitive agreements for the issuance and sale of 3,012,049 of its common shares and preferred investment options to purchase up to an aggregate of 3,012,049 common shares, at a purchase price of $0.83 per share (or pre-funded warrant in lieu thereof) and associated preferred investment option in a private placement priced at-the-market under Nasdaq rules... READ MORE

Lonza’s Rapid PyroCell® Monocyte Activation Test Systems Make Rabbit-Free Pyrogen Testing Faster, Easier, and More Efficient

Lonza has launched two new rapid monocyte activation test (MAT) systems, the PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, to streamline and simplify rabbit-free pyrogen testing. The systems, which will replace Lonza’s current MAT system kit offerings, contain the new PeliKine Human IL-6 Rapid ELISA Kit that minimizes hands-on time and reduces time-to-results from two days to two hours... READ MORE

Renaissance BioScience Secures Landmark Patent for Revolutionary RNA Production and Delivery Technology

Renaissance BioScience Corp. is pleased to announce that it has been awarded the first patent for its innovative yeast-based platform technology for the production and delivery of RNA bioactive molecules. The patent joins the company’s extensive IP portfolio of 50 patents issued previously for other innovations and 11 additional applications currently pending in key markets around the world with favourable outcomes anticipated... READ MORE

SnapCyte Solutions Inc. Receives Mitacs Grant for AI-Powered Cell Analytics Tools

SnapCyte Solutions Inc. has received a Mitacs Accelerate Grant for the project ‘Developing cutting-edge AI-powered tools to perform cell analytics in life science research laboratories’. The project will be undertaken by Dr. Jason Wong, PhD, under the supervision of CSO Nader Al-Nakouzi, PhD. The grant totals CAD $120,000... READ MORE

Blood Test Detects Tumours Early in Families With Cancer

Researchers funded by The Terry Fox Research Institute have demonstrated that by analyzing patients’ blood samples, they are able to detect cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with an almost 100 percent lifetime risk of developing cancer... READ MORE

adMare BioInnovations Launches the Refreshed Version of the adMare Community with New Engaging Features

adMare BioInnovations is proud to launch the enhanced adMare Community, a revamped online platform with several new, more advanced and efficient features, dedicated to nurturing the Canadian life sciences ecosystem and harnessing the collaborative power of our community. The adMare Community is the ultimate hub for discovering, connecting, and accessing Canada’s life sciences sector... READ MORE

Evonik Launches GMP-Quality Plant-Based Squalene

Evonik’s non-animal-derived squalene PhytoSquene® is now available produced under GMP. Launched last year, PhytoSquene®, is the first GMP amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. By offering plant-based squalene, Evonik is meeting the demand for a secure commercial supply of squalene for pharmaceutical applications, which is currently refined from shark liver oil... READ MORE

NervGen Pharma Receives Fast Track Designation For NVG-291 For The Treatment Of Individuals With Spinal Cord Injury

NervGen Pharma Corp. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its proprietary lead compound, NVG-291, in individuals with spinal cord injury (SCI). FDA’s Fast Track program is designed to facilitate the development of drugs intended to treat serious conditions and fill unmet medical needs as part of the FDA’s goal to get important new drugs to patients earlier... READ MORE

Pfizer Canada and the Skin Spectrum Summit Reveal Recipients of New Scholarship to Improve Dermatological Care For Racialized Canadians

Pfizer Canada and the Skin Spectrum Summit are pleased to announce the winners of the new Canadian Skin of Colour & Diversity Scholarship program, which aims to improve dermatological care for underrepresented populations, including those with deeper skin tones, Indigenous Peoples, and other racialized individuals... READ MORE

Groundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Line Advanced Bladder Cancer

Risk of death was reduced by 53% in patients treated with enfortumab vedotin plus pembrolizumab compared to chemotherapy. Enfortumab vedotin plus pembrolizumab improved median overall survival by more than 15 months vs. chemotherapy. Results will form the basis of global regulatory submissions... READ MORE

TIVDAK® (tisotumab vedotin-tftv) Significantly Prolonged Overall Survival in Patients with Recurrent or Metastatic Cervical Cancer Compared with Chemotherapy in Global Phase 3 innovaTV 301 Trial

TIVDAK demonstrated superior overall survival, progression-free survival and objective response rate compared to chemotherapy in late-breaking results presented at ESMO 2023 congress. Results from innovaTV 301 intended to serve as pivotal confirmatory trial for U.S. accelerated approval and to support global regulatory applications.. READ MORE

ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congress

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced the presentation of updated dose escalation data from its Phase 1/2 study evaluating masofaniten (formerly EPI-7386) in combination with enzalutamide at the European Society of Medical Oncology (ESMO) 2023 Congress, taking place October 20-24, 2023, in Madrid, Spain... READ MORE

Aequus Announces New Financing

Aequus Pharmaceuticals Inc., announces it has increased its debt by $1,000,000 to support operating costs and the new sales of Zimed® PF. Mr. Doug Janzen, Chairman and Chief Executive Officer of the Company, has agreed to provide financing to Aequus by way of advanced funds on the same general conditions as previous advances, which is on demand with an interest rate of five percent (5%)... READ MORE

FDA Approves Cabtreo (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel For The Treatment Of Acne Vulgaris In Patients Twelve Years Of Age And Older (Oct. 20)

​Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its dermatology business, Ortho Dermatologics, announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for CABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, indicated for the topical treatment of acne vulgaris in patients twelve years of age and older... READ MORE

Correcting and Replacing Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 2, 2023

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) announced that it will release financial and operational results for the third quarter of 2023, on Thursday, November 2, 2023, before markets open. Aurinia’s management team will host a conference call/webcast at 8:30 am ET that day to review these results and provide a general business update... READ MORE

New Provincial Funding Supports Research to Improve Pain Management for B.C. Children

UBC’s Dr. Catrina Loucks is among the recipients of new funding from the B.C. government for her research aimed at improving pain management for vulnerable B.C. children, including those with cancer and other conditions. Dr. Loucks, assistant professor in the Faculty of Medicine’s department of pediatrics and department of anesthesiology, pharmacology and therapeutics, is the principal investigator at the Loucks Pain Management Pharmacogenomics Lab at BC Children’s Hospital Research Institute... READ MORE

Interior Health is proud to deliver high-quality health-care services to the communities and visitors of the Southern Interior of British Columbia. We strive to set new standards of excellence in the delivery of health services in the province of B.C. and our mission is to promote healthy lifestyles and provide needed health services in a timely, caring and efficient manner, to the highest professional and quality standards.

Our uniqueness is in who we are and where we are. Our geographical location offers the choice of an active urban lifestyle or quiet rural setting. Whether you’re in clinical care, management, or in a supporting role, your impact will be felt. Your passion and motivation combined with our commitment to set new standards of excellence makes Interior Health the right choice for you. We thrive as a direct result of state-of-the-art equipment, forwarding thinking and strong leadership. We are here for your whole life from career choices to family benefits to work/life balance. At Interior Health there is always room to grow. LEARN MORE

Minister Valdez Wraps up Small Business Week by Highlighting Government Support for Entrepreneurs

Throughout Small Business Week 2023, the Honourable Rechie Valdez, Minister of Small Business, travelled across the country to meet with small business owners and stakeholders to highlight how the Government of Canada continues to support small businesses and helps them grow, innovate and adapt to changing times. Minister Valdez kicked off Small Business Week on Monday by announcing nearly $3 million in funding for the École des entrepreneurs du Québec to help 2000 women entrepreneurs across Canada start up and put their plans for growth into action... READ MORE

Government of Canada Announces New Appointment to the Patented Medicine Prices Review Board

The Honourable Mark Holland, Minister of Health, announced a new appointment to the Patented Medicine Prices Review Board (PMPRB). Following a merit-based selection process, Dr. Emily A. Reynen has been appointed to the Board for a five-year term. The Government of Canada is committed to appointing highly-qualified candidates to best serve the interests of Canadians and is committed to open, transparent, and merit-based processes for selecting Governor in Council appointees... READ MORE

Government of Canada and Partners Invest More Than $26 Million to Advance Integrated Health Care in Canada

Canadian Institutes of Health Research — Health research is vital for improving people’s health, advancing health equity, and strengthening Canada’s health care systems. This is especially true of implementation science: research that seeks to support the uptake of evidence-based solutions by policymakers and health care providers to improve patient care and health outcomes... READ MORE

Government of Canada Announces $9.9 Million to Scale Up B.C. Technology Businesses and Improve Productivity

British Columbia is home to hundreds of the most innovative technology companies in the world. By connecting them with large-scale B.C. organizations looking for sustainable solutions, these companies can test their new products and services, and grow their markets at home and abroad. The Honourable Harjit S. Sajjan, Minister of Emergency Preparedness and Minister responsible for the Pacific Economic Development Agency of Canada (PacifiCan), announced $9.9 million in PacifiCan funding to Innovate BC to help establish and grow the Integrated Marketplace... READ MORE

Minister Valdez Announces $500,000 for the Canadian Council for Aboriginal Business to Support Indigenous Entrepreneurs

Advancing Indigenous economic self-determination is a crucial part of the Government of Canada’s commitment to renewing the relationship with Indigenous Peoples. This means supporting the thousands of Indigenous entrepreneurs and small businesses working to create jobs and opportunity in their communities... READ MORE

Associate I

The QC Associate is responsible for performing routine samples analysis in accordance with GMP and Evonik policies and practices. The QC Associate will also assist with equipment calibration/qualification and analytical method validation, as well as participating in quality system improvement initiatives. This is a lab-based position which will entail a high volume of testing in a regulated laboratory environment...LEARN MORE

Senior Manager, Site Engagement Lead

The role involves leading strategic partnerships with key clinical trial sites, ensuring collaboration and operational efficiency, and serving as a subject matter expert. The responsibilities include maintaining strong relationships with sites, sharing insights, resolving issues, and centralizing operational information to enhance clinical trial execution, while also collaborating with internal stakeholders and contributing to process improvements...LEARN MORE

Principal Scientist/Associate Director Biologics

Abdera Therapeutics is seeking a highly motivated and skilled leader in antibody discovery with a proven track record of antibody campaigns. This position will provide an exciting and dynamic opportunity to positively contribute to and lead research programs and teams developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Mitacs Post-Doc

A postdoctoral position is available in the laboratory of Prof. Filip Van Petegem at the University of British Columbia. The goal is to apply state of the art computational protein design methods to create novel protein molecules to enable structural cryo-EM characterization of therapeutic candidates and their target. The project is a collaboration with Amgen, one of the world’s leading biotechnology companies, and is supported through a MITACS scholarship...LEARN MORE

Scientist, Clinical Pharmacokinetics

This role represents Clinical Pharmacology in multi-functional teams supporting late-stage discovery programs. It involves analyzing clinical PK data, assisting in study design, maintaining knowledge of drug development approaches, and contributing to regulatory and scientific documentation. The position also requires building client relationships, summarizing and presenting results, and coordinating with SAS programmers and Clinical Operations for efficient deliverables...LEARN MORE

Associate Scientist, In Vivo Pharmacology

This role involves overseeing in vivo immuno-oncology experiments, managing internal and external studies, and providing hands-on support for mouse handling and administrative tasks. It also encompasses pharmacodynamic evaluations, technology exploration, mentorship, result presentation, and ensuring compliance with scientific standards and regulations while promoting collaboration...LEARN MORE

Research Associate I, Analytics

The role involves conducting experiments, providing research support, and performing antibody/antigen purification through chromatography techniques. Additionally, it includes supporting protein characterizations, maintaining scientific standards, and fostering collaborative working relationships within the organization while adhering to safety regulations and documentation procedures. The position also entails maintaining a safe and organized laboratory environment and ensuring the procurement and organization of reagents and chemicals for the Analytics team...LEARN MORE

Quality System Specialist

To succeed in this role, the applicant must be a strong Quality partner/ collaborator to drive operational efficiencies to achieve sustainable quality compliance and meet the business objectives of the site. Build strong relationships with the Quality team, internal stakeholders (such as Development & Formulation, Supply Chain, Project Management, etc.) and external suppliers to assure on-time delivery of products/ materials/ services that are quality compliant and fit for its intended purpose...LEARN MORE

Research Associate-Protein Biochemistry

Abdera Therapeutics is seeking a highly motivated and skilled Research Associate in antibody discovery programs. This position will provide an exciting and dynamic opportunity to positively contribute to research programs developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Senior Scientist Biologics

Abdera Therapeutics is seeking a highly motivated and skilled Senior Scientist in antibody discovery programs with a proven track record of research accomplishments. This position will provide an exciting and dynamic opportunity to positively contribute to research programs developing next-generation targeted radiopharmaceutical therapies...LEARN MORE

Research Associate II, Analytics

The candidate should have expertise in high-performance liquid chromatography (HPLC), mass spectrometry, and protein biochemistry for protein characterization. Experience with various extraction techniques, Agilent™ or Waters™ HPLC and mass spectrometry equipment, AKTA™ purification systems, biological matrices like plasma and serum, and Orbitrap™ mass spectrometry instrumentation would be advantageous. General knowledge of antibody and antibody drug conjugate structure/function is also considered a valuable asset...LEARN MORE

Animal Research Associate II

This role involves applying preclinical mouse pharmacology models for cancer therapy research. Responsibilities include handling mice for various procedures, preparing drugs using sterile techniques, managing human immune cell injections, coordinating sample handling, maintaining records, and ensuring adherence to scientific standards and regulations. Effective organization, teamwork, and adherence to established protocols are essential, while fostering collaborative relationships with colleagues and management is encouraged...LEARN MORE

Senior Research Associate I, In Vitro Pharmacology

This position involves planning and executing advanced experiments, troubleshooting methods, and independently analyzing and interpreting data. The role includes designing animal studies, contributing to project planning and coordination, staying updated on relevant scientific literature, maintaining inventory databases, and potentially training junior staff. The candidate is expected to adhere to scientific standards, safety regulations, and lab protocols while actively contributing to collaborative work environments and potentially co-authoring scientific papers...LEARN MORE

Scientist, DMPK/ADME

If you are selected for this position, you will be lead oversight of contract research partners and in-house development of in vitro DMPK assays, contributing to their optimization and methodology enhancement. Independently design experiments for assessing pharmacokinetics and pharmacodynamics of small molecules and ADCs, establishing in vitro to in vivo correlations, and collaborating across disciplines to advance drug development programs. Maintain up-to-date knowledge in drug metabolism and pharmacokinetics, adhere to data generation protocols, and foster collaborative relationships with colleagues and management...LEARN MORE

Associate Scientist, In Vivo Pharmacology

The ideal candidate should have expertise in xenograft, syngeneic, or humanized mouse tumor models (PBMC/CD34) and a strong grasp of immune cell function. Proficiency in animal handling, dosing, and sample collection, especially tail vein injections, is essential. They should also demonstrate knowledge of in vivo cancer models, antibody-based therapeutics, immune cell isolation, strong organizational skills, experience with contract research organizations, and effective teamwork within scientific project teams...LEARN MORE

Ascinta Technologies Inc provides a web-based platform and application ecosystem for simplifying medical image analysis in clinical trials. Their AI-enabled solutions can eliminate manual image analysis, save time, and enable routine reporting of new biomarkers. Their platform is user-friendly, requires no coding, and available to anyone on the web with inexpensive and flexible payment plans. LEARN MORE

D2type Health is innovating in the realm of digital health, providing a transformative platform that empowers individuals managing diabetes to take control of their health through AI-guided insights and personalized coaching, fostering positive lifestyle changes and improved health outcomes. LEARN MORE

EyeCareX Technologies’ goal is to digitize elements of the eye exam and eye exam process allowing for an entirely new eye health patient journey. This transformative technology will not only allow significant lift in optometrist productivity and efficiency (ultimately yielding a 400% increase in revenue capabilities and reduction in optometrist opex); but more importantly, allowing for more effective, accessible, and affordable eye care for the public, saving countless lives from blindness- an epidemic that costs Canada ~$25 billion annually. LEARN MORE

Canadian Nano Pharmaceutical Technology Inc. (CNANO) is a pioneering pharmaceutical company focused on advanced drug delivery. Their patented nano-structured sustained-release topical systems provide precise control over release on different skin layers, delivering drugs efficiently through the skin and surpassing conventional methods by up to 15 times. Aligned with industry trends, they prioritize patient well-being and eco-friendliness, spanning pharmaceuticals, natural health, biologics, and cosmeceuticals. LEARN MORE

Stay current by subscribing to this and our events newsletter!

Follow LSBC on Social Media!